9.3 Bleeding in Pregnancy: Spontaneous Abortion, Ectopic Pregnancy & Placental Disorders
Key Takeaways
First-trimester bleeding differential diagnosis centers on spontaneous abortion subtypes, ectopic pregnancy, and molar gestation; evaluation mandates quantitative serum beta-hCG, transvaginal ultrasonography, and maternal Rh(D) status determination.
Spontaneous abortion is categorized by cervical os status and tissue passage: threatened (closed os, cardiac activity present), inevitable (open os, cramps, no tissue passed), incomplete (open os, partial tissue passage), complete (closed os, all tissue expelled), and missed (closed os, embryonic demise).
More than 95% of ectopic pregnancies are tubal, most in the ampulla (~70%); diagnosis combines serial hCG and TVUS (an empty uterus above the discriminatory level, which ACOG says may be as high as 3,500 mIU/mL) with an abnormal hCG trajectory (<35% rise over 48 hours).
Medical management of ectopic pregnancy with single-dose intramuscular methotrexate (50 mg/m² BSA) requires hemodynamic stability, unruptured mass <3.5 cm, absent embryonic cardiac activity, baseline hCG <5,000 mIU/mL, and normal hepatic/renal function, monitored on Days 4 and 7.
Late-pregnancy bleeding mandates immediate ultrasound before digital pelvic examination: placenta previa manifests with painless bright red bleeding (digital exam strictly contraindicated), placental abruption presents with painful dark bleeding and uterine tetany, and vasa previa features painless bleeding with acute fetal exsanguination at membrane rupture.
First-Trimester Bleeding: Differential Diagnosis of Spontaneous Abortion
First-trimester vaginal bleeding complicates approximately 20% to 25% of all clinically recognized pregnancies. Initial clinical assessment requires vital sign stabilization, speculum examination to identify the bleeding source and cervical os status, quantitative serum beta-hCG, transvaginal ultrasonography (TVUS), and maternal ABO and Rh(D) blood typing.
Spontaneous Abortion Subtypes
Early pregnancy loss refers to the non-viable intrauterine pregnancy up to 12 6/7 weeks gestation. Clinical subtyping dictates therapeutic intervention:
| Subtype | Cervical Os Status | Products of Conception (POC) | Clinical Manifestations & Sonographic Findings |
|---|---|---|---|
| Threatened Abortion | Closed internal os | Intact in utero | Vaginal bleeding with or without mild cramping. TVUS confirms viable intrauterine pregnancy with detectable embryonic cardiac activity. |
| Inevitable Abortion | Open internal os | Intact in utero (unexpelled) | Vaginal bleeding and moderate-to-severe cramping. Cervical effacement/dilation present; gestational sac or membranes visible at or bulging into external os. |
| Incomplete Abortion | Open internal os | Partial passage of POC | Heavy vaginal bleeding, severe cramping, and passage of tissue fragments. TVUS demonstrates thick, irregular, heterogeneous retained tissue within the cavity. |
| Complete Abortion | Closed internal os | Complete expulsion of all POC | History of heavy bleeding and tissue passage, now subsided into light spotting. TVUS shows an empty uterine cavity with a thin, regular endometrial stripe. |
| Missed Abortion | Closed internal os | Retained non-viable embryo | Minimal spotting or asymptomatic; cessation of pregnancy symptoms. TVUS demonstrates crown-rump length (CRL) ≥7 mm without cardiac activity or mean sac diameter ≥25 mm without an embryo. |
| Septic Abortion | Open or closed os | Retained infected POC | Intrauterine infection presenting with maternal fever, chills, tachycardia, malodorous purulent cervical discharge, uterine/pelvic peritonitis, and leukocytosis. |
Management of Early Pregnancy Loss
- Threatened Abortion: Expectant management and reassurance. Bed rest and pelvic rest are frequently advised, though evidence demonstrates bed rest does not alter clinical trajectory.
- Incomplete, Inevitable, or Missed Abortion:
- Expectant Management: Safe for stable patients in the first trimester; complete expulsion occurs within 2 to 4 weeks in 70% to 80% of cases.
- Medical Management: Misoprostol 800 mcg vaginally (or 600 mcg sublingually), with a repeat dose (no sooner than 3 hours and typically within 7 days) if expulsion is incomplete (ACOG Practice Bulletin 200). Pre-treatment with oral mifepristone 200 mg 24 hours prior significantly increases complete expulsion rates.
- Surgical Management: Manual vacuum aspiration (MVA) or electric suction curettage; indicated for heavy hemorrhage, hemodynamic instability, intrauterine infection, or patient preference.
- Septic Abortion: Medical emergency. Prompt initiation of broad-spectrum intravenous antibiotics (e.g., ampicillin, gentamicin, and clindamycin) followed by immediate surgical uterine evacuation.
- Rh Prophylaxis: For pregnancy loss or abortion before 12 weeks, ACOG's 2024 Clinical Practice Update suggests forgoing routine Rh testing and Rho(D) immune globulin (it may be offered on request). At 12 weeks or later, give 300 mcg Rho(D) immune globulin to unsensitized Rh(D)-negative patients.
Ectopic Pregnancy: Diagnostic Triad & Algorithms
Ectopic pregnancy occurs when a blastocyst implants outside the endometrial cavity. Over 95% implant in the fallopian tube (ampulla ~70%, isthmus ~12%, fimbriae ~11%, and interstitium/cornua ~2–3%). Cornual/interstitial pregnancies carry a catastrophic risk of fatal maternal hemorrhage at 8 to 12 weeks gestation due to extensive myometrial vascularity.
Clinical Presentation & Risk Factors
- Classic Triad: Amenorrhea (or abnormal menses), unilateral pelvic or lower abdominal pain, and vaginal bleeding.
- Rupture Signs: Sudden severe sharp pelvic pain, syncope, hypotension, involuntary guarding/rebound, or referred shoulder pain (Kehr sign) resulting from diaphragmatic irritation by hemoperitoneum.
- Major Risk Factors: Prior ectopic pregnancy (highest risk; ~10% recurrence), history of pelvic inflammatory disease (PID) or salpingitis, prior tubal reconstructive surgery or tubal ligation, conception with an intrauterine device (IUD) in situ, assisted reproductive technology (ART), and cigarette smoking.
Diagnostic Algorithm: The Discriminatory Zone
Combining serial quantitative serum beta-hCG and transvaginal ultrasonography (TVUS) is the diagnostic cornerstone:
- Discriminatory Zone: The serum beta-hCG concentration above which a normal intrauterine gestational sac with a yolk sac should be reliably visualized on TVUS. Many centers use 1,500 to 2,000 mIU/mL, but ACOG notes it may be as high as 3,500 mIU/mL; one hCG value should not prompt treatment of a possibly viable pregnancy.
- Diagnostic Interpretation:
- If serum beta-hCG is above the discriminatory level and TVUS shows an empty uterine cavity, an ectopic or nonviable pregnancy is strongly suspected.
- If serum beta-hCG is <1,500 mIU/mL and TVUS is non-diagnostic (pregnancy of unknown location [PUL]), obtain serial beta-hCG measurements 48 hours apart.
- hCG Doubling Kinetics: A normal viable intrauterine pregnancy exhibits a rise of at least 35% to 50% over 48 hours. A subnormal rise, plateau, or erratic decline confirms an abnormal gestation (ectopic vs. failing IUP).
Medical vs. Surgical Management of Ectopic Pregnancy
Medical Therapy: Methotrexate Protocol
Methotrexate (MTX) is a folic acid antagonist that halts dihydrofolate reductase, arresting DNA synthesis and cellular proliferation in actively dividing trophoblastic cells.
- Inclusion Criteria for MTX:
- Hemodynamically stable with no peritoneal signs.
- Unruptured ectopic mass <3.5 cm in greatest dimension on ultrasound.
- Absence of embryonic cardiac activity on sonography.
- Baseline serum beta-hCG concentration <5,000 mIU/mL (higher levels correlate with steep failure rates).
- Normal baseline hepatic enzymes (AST/ALT), renal function (creatinine), and complete blood count.
- Patient willing and able to comply with mandatory post-treatment surveillance.
- Absolute Contraindications: Hemodynamic instability, ruptured ectopic pregnancy, intrauterine pregnancy (heterotopic), renal dysfunction, hepatic disease, active pulmonary disease, severe anemia or thrombocytopenia, active peptic ulcer disease, or breastfeeding.
- Dosing Protocol (Single-Dose): 50 mg/m² body surface area (BSA) administered as an intramuscular injection on Day 1.
Post-Methotrexate Surveillance
- Measure serum beta-hCG on Day 1, Day 4, and Day 7.
- A transient increase in beta-hCG between Day 1 and Day 4 is expected as trophoblastic tissue lyses.
- Compare Day 4 and Day 7 levels: Successful response requires a ≥15% decrease in serum beta-hCG between Day 4 and Day 7.
- If beta-hCG decreases ≥15%: Follow weekly beta-hCG levels until undetectable (<5 mIU/mL).
- If beta-hCG fails to decrease <15%: Administer a second dose of MTX (50 mg/m²) on Day 7 or proceed to surgical intervention.
- Patient Counseling: Avoid folic acid supplements (blunts MTX efficacy), NSAIDs (impairs renal clearance of MTX), vigorous exercise/intercourse (prevents mechanical rupture), and sun exposure (photosensitivity).
Surgical Therapy
Indicated for hemodynamically unstable patients, ruptured ectopic pregnancy, contraindications to or failure of methotrexate, ectopic mass ≥3.5 cm, detectable fetal cardiac motion, or concurrent desire for permanent sterilization.
- Laparoscopic Salpingectomy: Complete surgical excision of the involved fallopian tube. Preferred procedure in cases of severe tubal destruction, extensive hemorrhage, or completed childbearing.
- Laparoscopic Salpingostomy: Linear incision along the antimesenteric border of the tube, gentle hydrodissection/removal of the ectopic trophoblast, allowing secondary intention closure. Indicated when the contralateral fallopian tube is absent or damaged to preserve future fertility; requires serial weekly beta-hCG monitoring to exclude persistent trophoblastic tissue.
Late-Pregnancy Bleeding: Placental Disorders & Emergencies
Second- and third-trimester vaginal bleeding requires urgent evaluation. The primary clinical imperative is to determine placental localization via ultrasound BEFORE any digital pelvic or cervical examination is performed.
| Disorder | Bleeding Character | Pain / Uterine Tone | Fetal Heart Rate Tracing | Hallmark Features & Management |
|---|---|---|---|---|
| Placenta Previa | Painless, bright red blood | Soft, non-tender, relaxed uterus | Typically normal / reassuring | Placenta covers internal os. Digital exam strictly contraindicated. Cesarean delivery at 36 0/7–37 6/7 weeks. |
| Placental Abruption | Painful, dark red blood (or concealed) | Hypertonic, tetanic, rigid, tender uterus | Late decelerations, bradycardia, loss of variability | Premature placental detachment. Maternal DIC, consumptive coagulopathy. Emergency delivery if unstable. |
| Vasa Previa | Painless, bright red blood | Soft, non-tender uterus | Abrupt, severe bradycardia or sinusoidal pattern | Fetal vessels traverse membranes over os. Membrane rupture causes fetal exsanguination. Emergency cesarean. |
| Uterine Rupture | Variable vaginal bleeding | Sudden, severe, tearing pain; cessation of contractions | Prolonged, severe bradycardia / terminal deceleration | Disruption of uterine wall (prior cesarean/TOLAC). Loss of fetal station. Immediate laparotomy. |
Placenta Previa
- Definition: Implantation of the placenta over or immediately adjacent to the internal cervical os. Current terminology uses placenta previa (placenta covers the internal os) and low-lying placenta (edge within 2 cm of the os); older terms such as marginal or partial previa are no longer used.
- Presentation: Sudden episodes of painless, bright red vaginal bleeding in the late second or third trimester.
- Mandatory Rule: NEVER perform a digital cervical examination in a patient with third-trimester bleeding until transabdominal or transvaginal ultrasound has completely excluded placenta previa. Digital palpation can disrupt the placental cotyledons, triggering catastrophic, exsanguinating hemorrhage.
- Management: Pelvic rest, avoidance of strenuous activity, and scheduled cesarean delivery at 36 0/7 to 37 6/7 weeks gestation.
Placental Abruption (Abruptio Placentae)
- Pathophysiology: Premature separation of a normally implanted placenta from the uterine myometrium before delivery, leading to decidual hemorrhage and hematoma formation.
- Risk Factors: Maternal chronic hypertension or preeclampsia (most common), blunt abdominal trauma (motor vehicle accident, falls, intimate partner violence), cocaine or amphetamine abuse, cigarette smoking, rapid uterine decompression (e.g., following membrane rupture with polyhydramnios), and prior abruption.
- Presentation: Painful, dark red vaginal bleeding (concealed behind retroplacental clot in 20% of cases), sudden severe abdominal or lower back pain, frequent high-frequency contractions progressing to uterine hypertonicity (woody/rigid uterus), and uterine tenderness.
- Complications: Consumptive coagulopathy with disseminated intravascular coagulation (DIC) driven by systemic release of decidual tissue factor, maternal hypovolemic shock, fetal hypoxia, and stillbirth.
A 27-year-old G2P1 at 31 weeks gestation presents to the obstetric triage unit with a sudden episode of moderate, painless, bright red vaginal bleeding that began 1 hour ago while resting. She reports no abdominal pain, uterine cramping, or trauma. Vital signs are: BP 118/74 mmHg, HR 76 bpm, and RR 16 breaths/min. Transabdominal fetal monitoring reveals a baseline fetal heart rate of 144 bpm with moderate variability and no uterine contractions. What is the most critical immediate action that must be AVOIDED during the initial assessment?
Performing transabdominal ultrasonography to determine placental position.
Drawing maternal blood for type and screen and complete blood count.
Applying external electronic fetal and tocodynamometer monitoring.
Performing a digital pelvic examination to assess cervical dilation and effacement.
A 24-year-old G1P0 at 6 weeks 3 days gestation presents to the clinic with light vaginal spotting and intermittent right lower quadrant aching over the past 2 days. She is hemodynamically stable: BP 120/78 mmHg, HR 72 bpm. Quantitative serum beta-hCG is 2,400 mIU/mL. Transvaginal ultrasonography reveals an empty uterine cavity with an endometrial stripe of 9 mm and a 2.1-cm unruptured complex right adnexal mass with no embryonic cardiac activity. Baseline complete blood count, serum creatinine, and liver transaminases are entirely normal. The patient desires fertility preservation and is committed to follow-up. What is the most appropriate management plan?
Perform immediate emergency exploratory laparotomy with right salpingectomy.
Administer single-dose intramuscular methotrexate (50 mg/m²) and measure serial beta-hCG levels on Days 4 and 7.
Repeat transvaginal ultrasound and serum beta-hCG in 48 hours to confirm abnormal doubling kinetics before intervening.
Perform an urgent dilation and curettage (D&C) followed by oral misoprostol 800 mcg.
A 34-year-old G3P2 at 35 weeks gestation with chronic hypertension presents with sudden, severe, continuous abdominal and back pain accompanied by dark red vaginal bleeding. On physical examination, the abdomen is firm, board-like, and exquisitely tender to light palpation, and the tocodynamometer reveals continuous high-frequency uterine hypertonicity. Electronic fetal monitoring demonstrates repetitive late decelerations with a baseline fetal heart rate of 105 bpm. What is the most likely diagnosis?
Placental abruption (abruptio placentae)
Placenta previa (complete or marginal)
Vasa previa with ruptured fetal vessels
Cervical insufficiency with advanced dilation
Sections you finish are checked off in the contents.